GGrantIndex
← Search

NANO2 ENHANCES IMMUNOTHERAPY IN TRIPLE NEGATIVE BREAST CANCERS.

$900,418FY2022Defense Health AgencyDOD

Nuvox Pharma, L.L.C.

Investigators

View source on USAspending →